Bulay, Wilfreda C.
HRN: 27-90-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2025
RIFAXIMIN 200MG (TAB)
10/07/2025
10/14/2025
ORAL
200mg
Tid
Hepatitis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes